Until dupilumab, which belongs to a new class of biologic drugs and is sold under the brand name Dupixent, emerged a few ...

Additionally, the use of room heaters to combat the cold weather outside can worsen your symptoms. If you are looking for ...

Living with eczema is more than just occasional flare-ups. It’s an ongoing struggle with relentless itching, redness, and ...

AnaptysBio will end the development of its experimental drug to treat eczema as the treatment failed to meet the goals of a ...

Q32 Bio delivered a "messy" update for its eczema and alopecia treatment, leading the biotech stock to collapse to a record ...

When conventional treatments for moderate to severe atopic dermatitis become less effective, targeted therapies may help.

Eczema-prone skin needn't mean a mundane moisturiser; our edit includes the ingredient-led, the fragranced and the luxurious ...

You only want the best when it comes to skin products for your baby, and that's especially true when your little one has ...

The US Food and Drug Administration (FDA) has approved nemolizumab for moderate-to-severe atopic dermatitis inadequately ...

Researchers believe they’ve discovered the hidden culprit behind eczema itch, paving the way for groundbreaking new treatment ...

Health Minister Mark Butler has struck a deal to secure the place of a “life-changing” eczema treatment on the Pharmaceutical ...

Chronic exposure to irritants, allergens, and repetitive hand washing are established risk factors for chronic hand eczema.